Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinostamustine in Advanced Solid Tumors
NCT03345485Phase 2Completed
- Sponsor
- Mundipharma
- Start
- Nov 2017
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of tinostamustine in solid tumor, small cell lung cancer (SCLC), soft tissue sarcoma (STS), triple-negative breast cancer (TNBC), ovarian cancer, sponsored by Mundipharma. Started Nov 2017; status: completed.
02
Drugs
tinostamustine
03
Conditions
solid tumorsmall cell lung cancer (SCLC)soft tissue sarcoma (STS)triple-negative breast cancer (TNBC)ovarian cancer
Beyond the preview
Go deeper on NCT03345485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03345485.